Largest pharmaceuticals by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 61 pharmaceuticals ranked by earnings, at DKK 182.7B, ahead of Eli Lilly (DKK 140.7B) and Merck & Co (DKK 124.4B). Figures as of 18 Nov 2026, 15:26 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonDKK 182.7B
- Median
- DKK 402.2M
- Combined market value
- DKK 34.79T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | DKK 182.7B | DKK 4.52T | DKK 1,877.90 | 1.15% down | 38% up | ||
| 2 | Eli LillyLLY · Health Care | DKK 140.7B | DKK 8.49T | DKK 9,529.12 | 1.24% down | 35% up | ||
| 3 | Merck & CoMRK · Health Care | DKK 124.4B | DKK 2.36T | DKK 956.38 | 2.14% down | 51% up | ||
| 4 | Novo NordiskNVO · Health Care | DKK 103.6B | DKK 1.2T | DKK 272.39 | 1.82% down | 17% down | ||
| 5 | NovartisNVS · Health Care | DKK 95.3B | DKK 2.02T | DKK 1,068.45 | 1.50% down | 25% up | ||
| 6 | AstraZenecaAZN · Health Care | DKK 69.7B | DKK 1.9T | DKK 1,224.95 | 1.41% down | 2% up | ||
| 7 | SanofiSNY · Health Care | DKK 59.1B | DKK 776.2B | DKK 323.24 | 0.23% down | 4% down | ||
| 8 | PfizerPFE · Health Care | DKK 53B | DKK 1.1T | DKK 192.43 | 0.84% down | 14% up | ||
| 9 | GSKGSK · Health Care | DKK 51.7B | DKK 669.6B | DKK 334.04 | 0.48% down | 6% up | ||
| 10 | Bristol-Myers SquibbBMY · Health Care | DKK 48.1B | DKK 837.3B | DKK 409.64 | 2.05% down | 34% up | ||
| 11 | Abbott LaboratoriesABT · Health Care | DKK 44.5B | DKK 1.23T | DKK 712.29 | 0.21% down | 17% down | ||
| 12 | Regeneron PharmaceuticalsREGN · Health Care | DKK 30.7B | DKK 677B | DKK 6,544.42 | 0.24% up | 36% up | ||
| 13 | AbbVieABBV · Health Care | DKK 28.8B | DKK 3.47T | DKK 1,964.97 | 1.55% down | 26% up | ||
| 14 | Vertex PharmaceuticalsVRTX · Health Care | DKK 26.9B | DKK 926.2B | DKK 3,653.01 | 0.32% up | 27% up | ||
| 15 | ZoetisZTS · Health Care | DKK 18.2B | DKK 233.5B | DKK 574.70 | 0.99% up | 29% down | ||
| 16 | Teva Pharmaceutical IndustriesTEVA · Health Care | DKK 9.6B | DKK 338.4B | DKK 290.04 | 0.16% down | 74% up | ||
| 17 | United TherapeuticsUTHR · Health Care | DKK 9.1B | DKK 167.1B | DKK 3,924.38 | 1.43% down | 23% up | ||
| 18 | GenmabGMAB · Health Care | DKK 6.6B | DKK 217.1B | DKK 352.07 | 0.60% down | 70% up | ||
| 19 | Royalty PharmaRPRX · Health Care | DKK 5.3B | DKK 268.9B | DKK 467.61 | 0.12% down | 78% up | ||
| 20 | PTC TherapeuticsPTCT · Health Care | DKK 4.7B | DKK 34.6B | DKK 413.62 | 0.53% up | 20% down | ||
| 21 | Dr. Reddy's LaboratoriesRDY · Health Care | DKK 3.1B | DKK 85.1B | DKK 102.12 | 1.29% up | 5% up | ||
| 22 | TG TherapeuticsTGTX · Health Care | DKK 3B | DKK 66.1B | DKK 437.41 | 2.33% up | 107% up | ||
| 23 | GrifolsGRFS · Health Care | DKK 3B | DKK 39.7B | DKK 58.35 | 0.81% down | 1% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | DKK 2.4B | DKK 79.3B | DKK 409.57 | 2.69% up | 11% up | ||
| 25 | Alnylam PharmaceuticalsALNY · Health Care | DKK 2.1B | DKK 140.9B | DKK 1,051.75 | 1.41% down | 66% down | ||
| 26 | BeOne MedicinesONC · Health Care | DKK 2B | DKK 316B | DKK 2,766.53 | 1.79% down | 17% up | ||
| 27 | AlkermesALKS · Health Care | DKK 1.6B | DKK 53B | DKK 315.26 | 1.76% up | 58% up | ||
| 28 | Ligand PharmaceuticalsLGND · Health Care | DKK 848.3M | DKK 40.5B | DKK 2,022.34 | 0.98% up | 43% up | ||
| 29 | Corcept TherapeuticsCORT · Health Care | DKK 679.3M | DKK 51.3B | DKK 469.11 | 1.78% down | 8% down | ||
| 30 | Amneal PharmaceuticalsAMRX · Health Care | DKK 491.2M | DKK 51.3B | DKK 147.37 | 2.37% up | 83% up | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | DKK 402.2M | DKK 51.7B | DKK 657.93 | 1.48% up | 126% up | ||
| 32 | Arrowhead PharmaceuticalsARWR · Health Care | -DKK 11.1M | DKK 41.9B | DKK 296.18 | 1.07% up | 10% up | ||
| 33 | Mirum PharmaceuticalsMIRM · Health Care | -DKK 159.3M | DKK 40.7B | DKK 623.09 | 0.59% down | 31% up | ||
| 34 | Travere TherapeuticsTVTX · Health Care | -DKK 174.1M | DKK 32.9B | DKK 343.24 | 1.46% down | 44% up | ||
| 35 | VeradermicsMANE · Health Care | -DKK 477.1M | DKK 36.1B | DKK 854.51 | 0.22% down | 233% up | ||
| 36 | Belite BioBLTE · Health Care | -DKK 529M | DKK 43.9B | DKK 1,081.19 | 0.57% up | 31% up | ||
| 37 | Oruka TherapeuticsORKA · Health Care | -DKK 718.7M | DKK 45B | DKK 663.38 | 1.04% up | 241% up | ||
| 38 | ErascaERAS · Health Care | -DKK 849M | DKK 32.3B | DKK 92.09 | 2.74% down | 403% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | -DKK 887.2M | DKK 56B | DKK 857.75 | 0.93% up | 46% up | ||
| 40 | Spyre TherapeuticsSYRE · Health Care | -DKK 1.1B | DKK 62.5B | DKK 658.37 | 2.96% up | 286% up | ||
| 41 | Dianthus TherapeuticsDNTH · Health Care | -DKK 1.1B | DKK 33.8B | DKK 599.99 | 1.20% up | 113% up | ||
| 42 | Edgewise TherapeuticsEWTX · Health Care | -DKK 1.1B | DKK 31B | DKK 283.19 | 1.18% down | 88% up | ||
| 43 | Axsome TherapeuticsAXSM · Health Care | -DKK 1.2B | DKK 48.1B | DKK 913.75 | 1.40% down | 7% down | ||
| 44 | Definium TherapeuticsDFTX · Health Care | -DKK 1.3B | DKK 27.2B | DKK 198.36 | 0.95% down | 169% up | ||
| 45 | Rhythm PharmaceuticalsRYTM · Health Care | -DKK 1.3B | DKK 55.8B | DKK 804.34 | 1.19% up | 13% up | ||
| 46 | Elanco Animal HealthELAN · Health Care | -DKK 1.6B | DKK 90.5B | DKK 180.98 | 2.71% up | 20% up | ||
| 47 | Ascendis PharmaASND · Health Care | -DKK 1.7B | DKK 121.5B | DKK 1,852.48 | 0.21% up | 28% up | ||
| 48 | Madrigal PharmaceuticalsMDGL · Health Care | -DKK 2B | DKK 66.3B | DKK 2,855.79 | 0.72% down | 24% down | ||
| 49 | Legend BiotechLEGN · Health Care | -DKK 2B | DKK 21.6B | DKK 111.38 | 1.43% up | 42% down | ||
| 50 | Roivant SciencesROIV · Health Care | -DKK 2B | DKK 193.5B | DKK 267.07 | 1.21% up | 90% up | ||
| 51 | Praxis Precision MedicinesPRAX · Health Care | -DKK 2.1B | DKK 58.7B | DKK 2,099.06 | 0.94% up | 61% up | ||
| 52 | Cogent BiosciencesCOGT · Health Care | -DKK 2.2B | DKK 34.1B | DKK 195.80 | 3.14% up | 20% down | ||
| 53 | Jazz PharmaceuticalsJAZZ · Health Care | -DKK 2.4B | DKK 106.8B | DKK 1,663.36 | 1.38% up | 37% up | ||
| 54 | ABIVAXABVX · Health Care | -DKK 2.5B | DKK 50B | DKK 570.71 | 1.98% up | 27% down | ||
| 55 | Ionis PharmaceuticalsIONS · Health Care | -DKK 2.6B | DKK 30.6B | DKK 183.98 | 0.11% up | 64% down | ||
| 56 | BridgeBio PharmaBBIO · Health Care | -DKK 5B | DKK 103.4B | DKK 530.59 | 1.35% up | 17% up | ||
| 57 | CytokineticsCYTK · Health Care | -DKK 5.4B | DKK 49.4B | DKK 354.87 | 0.79% up | 20% down | ||
| 58 | Takeda PharmaceuticalTAK · Health Care | -DKK 6.5B | DKK 466.3B | DKK 145.94 | 1.06% down | 54% up | ||
| 59 | Summit TherapeuticsSMMT · Health Care | -DKK 7.4B | DKK 59.3B | DKK 74.10 | 1.87% up | 36% down | ||
| 60 | InsmedINSM · Health Care | -DKK 8.7B | DKK 181.2B | DKK 826.09 | 0.55% down | 40% down | ||
| 61 | ViatrisVTRS · Health Care | -DKK 24B | DKK 161.1B | DKK 140.56 | 0.83% up | 96% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8165 DKK).
Questions and answers
Which pharmaceuticals rank first by earnings?
Johnson & Johnson (DKK 182.7B), Eli Lilly (DKK 140.7B) and Merck & Co (DKK 124.4B) are the top three of the 61 pharmaceuticals ranked by earnings as of 18 Nov 2026, 15:26 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by earnings.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by earnings have a combined market value of DKK 34.79T as of 18 Nov 2026, 15:26 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceuticals by earnings”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.